China Pharma Holdings (CPHI) Share-based Compensation Growth (1y) (2011 - 2025)
Powered by 
Analysis
China Pharma Holdings (CPHI) Share-based Compensation Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | -119.48% |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | -7.26% |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 37.96% |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 22.66% |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 4.11% |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | -49.74% |
| 10 | China Pharma Holdings | 31.39 Mn | 31.08 Mn | 83,566.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 563.95% |
| Dec 31, 2024 | 668.29% |
| Mar 31, 2024 | 110.00% |
| Dec 31, 2023 | -140.70% |
| Sep 30, 2023 | 530.00% |
| Jun 30, 2023 | -25.00% |
| Mar 31, 2023 | 116.67% |
| Dec 31, 2022 | -0.36% |
| Sep 30, 2022 | 1,212.08% |
| Mar 31, 2014 | -43.47% |
| Jun 30, 2013 | -365.73% |
| Mar 31, 2013 | 300.95% |
| Jun 30, 2012 | 112.72% |
| Mar 31, 2012 | 34.83% |
| Dec 31, 2011 | -10.53% |
| Sep 30, 2011 | -5.58% |